CHRNA7 and inflammatory bowel disease: Studies on α7 nAChR-mediated inflammation outside the central nervous system, research has focused on the modulating mechanisms of the α7 nAChR-mediated cholinergic anti-inflammatory pathway in inflammatory bowel disease, rheumatoid joints, atherosclerosis, and other diseases [35,36].